Company dossier
Glenmark Pharmaceuticals
NSE:GLENMARK · ISIN INE935A01035
- Close
- ₹2,261.7 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Glenmark Pharmaceuticals
Ownership
Shareholding pattern
Exchange XBRLOwnership by reported class
| Holder class | 30 Jun 26 | 31 Mar 26 | 31 Dec 25 | 30 Sept 25 | 30 Jun 25 | 31 Mar 25 |
|---|---|---|---|---|---|---|
| Promoter group | 46.65% | 46.65% | 46.65% | 46.65% | 46.65% | 46.65% |
| Public | 53.35% | 53.35% | 53.35% | 53.35% | 53.35% | 53.35% |
| Employee trust | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Next ownership layer
Planned enrichmentHolder-level detail
Mutual funds, foreign institutions, insurers, promoter entities, pledges and beneficial-owner changes will be added from detailed shareholding facts. This summary does not infer those classes.